Arestin Dental Code (D4381): Localized Antimicrobial

What D4381 covers

D4381 reports placing a controlled-release antimicrobial agent into a diseased periodontal pocket on a single tooth. The agent is an FDA-approved product that sits in the pocket and releases medication over time to suppress the bacteria driving the disease. In practice this is Arestin (minocycline microspheres), PerioChip (a chlorhexidine chip), or Atridox (a doxycycline gel), though the code describes the procedure, not a brand.

The code covers both the placement and the material in one line. There is no separate code for the drug, so the D4381 fee has to include the cost of the agent. A fee set as if it were placement only loses money on every unit.

Billed per tooth, never per site or quadrant

D4381 is counted per tooth. If one tooth gets antimicrobial at three separate pockets, that is still one unit of D4381, and the fee is expected to cover all the sites on it. This is the reverse of scaling and root planing (D4341 and D4342), which are reported by quadrant.

Put the tooth number on every line and never attach a quadrant. A claim showing D4381 three times for one tooth, or a quadrant where a tooth number belongs, gives a reviewer a clean reason to cut it back. The per-tooth rule is the part of this code most often gotten wrong.

Why same-day SRP is the most common denial

Carriers treat the antimicrobial as care for a pocket that stayed diseased after the tissue had a real chance to respond to scaling. If you scale and place Arestin in the same visit, you don’t yet know which pockets would have closed once the inflammation settled. Plans that cover D4381 commonly want a gap of six weeks to several months between SRP and placement, with a periodontal re-evaluation in between showing the pocket is still deep and inflamed.

That re-evaluation is often reported as D0180 (comprehensive periodontal evaluation) or a periodic perio evaluation, depending on the patient and the plan. It documents the “this pocket didn’t respond” finding the antimicrobial is meant to address.

Coverage reality: many plans don’t cover it at all

Coverage for D4381 varies more than for almost any code in the periodontal section. A number of carriers exclude localized antimicrobial delivery outright or classify it as investigational. Aetna, for example, lists it as not a covered service on most of its dental plans, with narrow exceptions for older plans that still carry the benefit.

Plans that do cover D4381 tend to require:

• An isolated residual pocket, typically 5mm or greater, that stayed diseased after scaling and root planing. Shallower pockets, or generalized placement across many sites, are where carriers most often call the treatment investigational.
• A healing interval after SRP, commonly six weeks to several months, with documentation that the pocket persisted.
• Active disease at the site: continued bleeding on probing, suppuration, or attachment loss, not just a number on a chart.
• A frequency limit. Some plans cap how often a tooth can be retreated, and clinically a site may be retreated years apart rather than at every recall.

Verify D4381 specifically when you check benefits: whether it is covered at all, the pocket-depth requirement, the timing rule, and any frequency cap. Where the patient is paying, give them the out-of-pocket number before the appointment, not on the statement.

When to bill D4381

Bill D4381 when an FDA-approved agent (Arestin, PerioChip, Atridox) is placed at a tooth with a residual or recurrent pocket, usually 5mm or deeper, that stayed inflamed after scaling and root planing and was still diseased at re-evaluation after a healing interval. It is an adjunct to the periodontal therapy the patient is already getting, not a replacement for mechanical therapy and not treatment for generalized disease or a fresh perio diagnosis. Report one unit per treated tooth.

Do not bill D4381 for:

• The scaling and root planing itself. That is D4341 (four or more teeth per quadrant) or D4342 (one to three teeth per quadrant).
• A full-mouth therapeutic scaling for generalized gingival inflammation with no bone loss. That is D4346.
• A full-mouth debridement to enable a later evaluation. That is D4355.
• Periodontal maintenance recall after active therapy. That is D4910, and an antimicrobial placed during a maintenance visit is its own D4381 line per tooth, not part of the maintenance fee.

Documentation that supports the claim

Carriers that cover D4381 want to see a residual pocket, not a routine add-on. The record, and the claim where the carrier accepts attachments, should capture:

• The tooth number for each unit billed.
• The pocket depth at the treated tooth, typically 5mm or greater, from current periodontal charting.
• The periodontal diagnosis and signs of active disease at the site: bleeding on probing, suppuration, or attachment loss.
• The prior SRP and its date, so the timeline shows the antimicrobial followed scaling rather than landing on the same day.
• A short narrative naming the tooth, pocket depth, prior SRP date, and product placed, written at the point of care rather than reconstructed after a denial.

Radiographs supporting the periodontal diagnosis help on plans that review these claims closely. A note that reads only “antibiotic placed” gives the carrier nothing to approve.